INFI - Infinity Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5107.09M
Enterprise Value 363.76M
Trailing P/E N/A
Forward P/E 1-2.65
PEG Ratio (5 yr expected) 1-0.03
Price/Sales (ttm)17.85
Price/Book (mrq)2.26
Enterprise Value/Revenue 310.63
Enterprise Value/EBITDA 6-1.85

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Mar 31, 2018


Profit Margin 0.00%
Operating Margin (ttm)-591.43%

Management Effectiveness

Return on Assets (ttm)-28.88%
Return on Equity (ttm)-68.47%

Income Statement

Revenue (ttm)6M
Revenue Per Share (ttm)0.12
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-14.83M
Net Income Avi to Common (ttm)-40.81M
Diluted EPS (ttm)-0.80
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)47.81M
Total Cash Per Share (mrq)0.85
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)10.80
Book Value Per Share (mrq)0.85

Cash Flow Statement

Operating Cash Flow (ttm)-28.79M
Levered Free Cash Flow (ttm)-17.99M

Trading Information

Stock Price History

Beta 2.38
52-Week Change 338.46%
S&P500 52-Week Change 313.55%
52 Week High 33.75
52 Week Low 30.93
50-Day Moving Average 31.92
200-Day Moving Average 32.07

Share Statistics

Avg Vol (3 month) 3540.27k
Avg Vol (10 day) 3209.74k
Shares Outstanding 556.07M
Float 40.72M
% Held by Insiders 12.91%
% Held by Institutions 162.07%
Shares Short (Jun 15, 2018) 41.58M
Short Ratio (Jun 15, 2018) 42.98
Short % of Float (Jun 15, 2018) 43.76%
Short % of Shares Outstanding (Jun 15, 2018) 42.82%
Shares Short (prior month May 15, 2018) 41.7M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/4
Last Split Date 3Sep 13, 2006